The EuChemS Industry Innovation Award honours outstanding achievements by researchers or teams of researchers working for industrial companies in the field of chemistry, or jointly by research teams from academia and/or from other research institutions.
Recipients of the EuChemS Industry Innovation Award
The first EuChemS Industry Innovation Award Awardees will be announced in 2025.
International Award Committee for the EuChemS Industry Innovation Award (IACIIA)
Yves Auberson
Yves P. Auberson obtained his Ph.D. in 1990 at the Swiss Federal Institute of Technology in Lausanne, Switzerland. He joined Novartis BioMedical Research in Basel, Switzerland, in 1992, after a post-doctoral training in chemical biology with Peter Schultz at Affymax, in Palo Alto, USA.
He is currently Executive Director in Global Discovery Chemistry at Novartis in Basel, where he leads the nuclear imaging agent discovery activities. Previously, he was Head of Chemistry for Neuroscience.
Yves P. Auberson played a leading role in the discovery and development of several drug candidates for epilepsy, Alzheimer’s disease, and narcolepsy, as well as of several clinical imaging agents for positron emission tomography. He is actively involved in the medicinal chemistry and chemical biology community, acting as Advisor to the Executive Committee of the European Federation for Medicinal Chemistry and Chemical Biology (EFMC), and as Vice-President of the Swiss Chemical Society.
Annette Doherty
Gaetano Guerra
András Kotschy
András Kotschy is the Director of the Servier Research Institute of Medicinal Chemistry in Budapest, Hungary and he also oversees the Medicinal Chemistry activities globally within Servier Research. After completing his PhD degree in organic chemistry in 1995 and some postdoctoral stays (Humboldt postdoctoral fellow with P. Knochel in München, RSC postdoctoral fellow with D.M. Smith in St Andrews) he joined the staff of Eötvös Loránd University in Budapest, where he rose through the ranks to associate professor also completing his habilitation and obtaining a DSc degree.
In 2007 he moved to the newly established Servier Research Institute of Medicinal Chemistry as director of the Discovery Chemistry division and in 2015 became director of the institute. Since 2020 he is also director of Medicinal Chemistry activities within Servier Research. He is the co-author of more than 90 refereed publications and co-inventor of more than 25 patents. He is also the recipient of multiple scientific awards and fellowships.